The LUTONIX™ 035 Drug Coated Balloon PTA Catheter is a cutting-edge medical device designed for minimally invasive vascular interventions. It combines advanced balloon technology with a drug-eluting coating to treat arterial blockages effectively. The catheter is engineered for precision and durability, ensuring optimal performance during angioplasty procedures.

1. The LUTONIX™ 035 features a drug-coated balloon that delivers paclitaxel directly to the arterial wall, reducing the risk of restenosis. The balloon is made from a blend of Nylon 12 and Pebax 4033, providing flexibility and strength.
2. The catheter's design includes radiopaque markers for accurate placement and GeoAlign measurement markers on some models for enhanced procedural precision. The drug coating consists of paclitaxel, polysorbate 20, and sorbitol, ensuring controlled drug release.
3. This catheter is specifically designed for treating stenoses in the superficial femoral or popliteal arteries. Its single-use, ethylene oxide-sterilized design ensures safety and efficacy, with a shelf life of 3 years.

The LUTONIX™ 035 Drug Coated Balloon PTA Catheter is a reliable and innovative solution for vascular interventions. Its drug-eluting technology and precise design make it a preferred choice for treating arterial blockages, ensuring better patient outcomes.

The LUTONIX™ 035 Drug Coated Balloon PTA Catheter offers advanced features for effective vascular treatment, including a drug-eluting balloon, precise placement markers, and a durable design.

1. The drug-coated balloon delivers paclitaxel directly to the arterial wall, reducing the risk of restenosis and improving long-term outcomes.
2. Radiopaque markers ensure accurate placement during procedures, enhancing procedural success rates.
3. GeoAlign measurement markers on some models provide additional precision for complex interventions.
4. The balloon is made from a blend of Nylon 12 and Pebax 4033, offering flexibility and strength for challenging anatomies.
5. The catheter is sterilized with ethylene oxide and designed for single use, ensuring safety and reliability.

The LUTONIX™ 035 combines innovative drug-eluting technology with precise engineering, making it a versatile and effective tool for vascular interventions. Its features ensure optimal performance and patient safety.

The LUTONIX™ 035 is clinically used for treating arterial blockages in the superficial femoral and popliteal arteries, offering a minimally invasive solution with reduced restenosis rates.

1. The catheter is used in percutaneous transluminal angioplasty (PTA) to treat new or recurrent stenoses in the lower extremities.
2. It is particularly effective for lesions up to 300mm in length, providing consistent drug delivery.
3. The drug-eluting balloon reduces the need for additional stenting, minimizing procedural complexity.
4. Clinical studies have shown improved patency rates and reduced restenosis compared to traditional PTA.
5. The catheter is suitable for patients with reference vessel diameters of 4mm to 7mm, ensuring broad applicability.

The LUTONIX™ 035 has proven clinical efficacy in treating arterial blockages, offering a minimally invasive and effective solution with long-term benefits for patients.

When purchasing the LUTONIX™ 035, consider product specifications, types, budget, and intended use to ensure optimal selection and application.

1. Evaluate the product specifications, including balloon size, drug dosage, and compatibility with your vascular intervention tools.
2. Choose the appropriate product type based on lesion length and vessel diameter requirements.
3. Plan your budget considering the cost-effectiveness of the drug-eluting technology and reduced need for additional stenting.
4. Assess the intended use, ensuring the catheter is suitable for the specific vascular anatomy and procedural requirements.

Selecting the right LUTONIX™ 035 involves careful consideration of product features, clinical needs, and budget. Its advanced technology ensures value and effectiveness in vascular interventions.

Proper handling and usage of the LUTONIX™ 035 are essential to ensure safety and efficacy. Follow guidelines for storage, preparation, and disposal.

1. Store the catheter in a cool, dry place and ensure it is within its shelf life before use.
2. Inspect the product for damage or defects before use, and do not use if compromised.
3. Follow aseptic techniques during preparation and use to prevent contamination.
4. Dispose of the catheter according to medical waste regulations after single use.
5. Monitor patients for adverse reactions post-procedure and provide appropriate care.

The LUTONIX™ 035 requires careful handling and adherence to safety protocols to maximize its benefits. Proper storage, usage, and disposal ensure patient safety and procedural success.